Navigation Links
Terumo Medical Corp. reports first US implant in landmark study enrolling in US and Japan
Date:9/9/2010

Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation, today announced the first U.S. patient implant in the Occlusive/Stenotic Peripheral artery REvascularization StudY (OSPREY), which will evaluate the safety and efficacy of its MISAGO Peripheral Self-expanding Stent System for use in the superficial femoral artery (SFA). The procedure was performed at the Bradenton Cardiology Center in Bradenton, Florida.

A unique feature of the OSPREY clinical trial is that it will simultaneously enroll patients in the U.S. and Japan. Referred to as "Medical Device Collaborative Consultation and Review of Premarketing Applications" under the larger Harmonization by Doing (HBD) initiative, the OSPREY trial was selected as one of two projects to pilot this approach, which is intended to shorten the gap between product approvals in these two significant world healthcare markets. The pilot program is a cooperative effort led by the U.S. Food & Drug Administration, the MHLW-PMDA (Japan's regulatory bodies), Terumo Corporation based in Tokyo, Japan, and Terumo Medical Corporation, a U.S.-based subsidiary of Terumo Corporation.

"We are pleased to be the first U.S. center to kick off this exciting international trial to evaluate the safety and efficacy of the MISAGO Stent System for treating patients with peripheral artery disease," said Srinivas Iyengar, MD, primary operator and site Principal Investigator for the OSPREY trial. "This is a unique and exciting opportunity for myself and the Bradenton Cardiology Center to be a part of the first international initiative to streamline the regulatory process to facilitate future medical device approvals between countries."

In the U.S., OSPREY is a single-arm, multi-center, non-randomized prospective clinical trial for the treatment of atherosclerotic stenoses and occlusions of the SFA. In Japan, there are two arms of the study, 50 patients receiving the MISAGO Stent System and 50 pat
'/>"/>

Contact: Robert Murphy
rmurphy@storchmurphy.com
908-276-0777
The Storch Murphy Group
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology news :

1. Developments in nanobiotechnology at UCSB point to medical applications
2. Novartis awards 2010 Prizes for Immunology in recognition of outstanding contributions to immunology in medical research
3. Montana State University offers 6 new biomedical technologies for licensing
4. OSA launches new journal, Biomedical Optics Express
5. What the doctor prescribes: Customized medical-image databases
6. Scientists at University of Colorado Anschutz Medical Campus discover new fat cell
7. Symposium to explore broadening partnerships to spur medical advances for war injuries
8. ACP Medical Laboratory Evaluation program gains approval from CAP accreditation program
9. UCI receives prestigious federal research award to hasten medical advances
10. Biomedical scientist concerned about effects of oil spill on human health
11. CIMIT announces $3 million in medical research grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... Elsevier, a world-leading provider of scientific, technical and medical ... launch of a new open access journal, GeoResJ ... , Elsevier,s earth and planetary science journals portfolio has ... to provide a forum for rapid publication of top ... will be co-edited by six Executive Editors, each covering ...
(Date:6/18/2013)... the University of Calgary,s Faculty of Medicine have discovered ... from harmful bacteria. Platelets, a component of blood typically ... specific bacteria, and upon detection, seal it off from ... published in Nature Immunology this week, provide ... , "The science community has known that platelets do ...
(Date:6/18/2013)... environmental engineer has been awarded a $394,300 grant ... water quality and flow in the new facilities ... Kruzic, UT Arlington associate professor of civil engineering, ... add monochloramine to the water in an effort ... stations and pipelines. Adding monochloramine is widely practiced ...
Breaking Biology News(10 mins):Immunity mechanism discovered 2UT Arlington research to benefit quality, flow in 150-mile Integrated Pipeline 2
... orchids have been found to rely on a wide ... of the soil instead of producing their own organic ... the open access journal BMC Biology , also ... and Mlanie Roy, from the Centre d,Ecologie Fonctionnelle et ...
... Carnegie Mellon University have developed an analytical technique to ... disease syndromes such as diabetes, asthma and cancer, which ... Rather than searching one at a time for genetic ... as in most conventional approaches, the Carnegie Mellon scientists ...
... Water striders, the familiar semi-aquatic bugs gliding across the ... allows them to walk on water. This was not ... evolution of a unique arrangement of the legs, with the ... of Ecology and Evolutionary Biology have discovered the gene behind ...
Cached Biology News:Carnegie Mellon develops innovative method to detect genetic causes of complex diseases 2
(Date:6/19/2013)... Clinverse, Inc. , a ... trials, today announced it will be exhibiting and ... in Boston, June 24-26, 2013. Clinverse’s eClinical ... fully configurable, cloud-based clinical financial lifecycle system. , ... Clinverse’s eClinical Commerce Network, automates site contract set-up ...
(Date:6/19/2013)... Calif. , June 19, 2013 ... plant, stool and other challenging microbial nucleic acid ... Protein Extraction Kit, for extraction of pure protein ... protein world coincides with the 20 th ... growing innovation capabilities. (Photo: http://photos.prnewswire.com/prnh/20130619/LA32633 ...
(Date:6/19/2013)... CLEVELAND , June 19, 2013   NineSigma ... announced that a year following its launch, NineSights.com ... and a focal point for the worldwide community of ... to climate and environmental sustainability experts, NineSights stands out ... broad range of scientific and technical disciplines, all vetted ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Today DuPont ... young people to become leaders in the greatest challenge ... billion people in 2050. Borel spoke at the ... Conference in Atlanta, about urgent need for students to ... are local, science-based, sustainable and reached in collaboration with ...
Breaking Biology Technology:Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2MO BIO Laboratories, Inc. launches the first kit for protein extraction from soil 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 2NineSigma Evolves Global Open Innovation through Social Media Platform, NineSights 3DuPont Leader Calls for New Generation of Food Visionaries to Fight Hunger 2
... Purpose , ... this series describes an LC/MS/MS method for the simultaneous determination ... FK-506), Sirolimus (SIR, aka Rapamycin) and Everolimus (EVE, aka RAD-001) ... robust hardware configuration and shows to be fast and simple, ...
... , ... As the study of protein biomarkers increases in ... protein pathway information and discovery-based proteomics experiments. Even larger numbers of ... gene expression studies or other genomic information. , ...
... Purpose , ... non-nucleoside reverse transcriptase inhibitor (NNRTI) antiretroviral drugs is of significant ... metabolism variability. To be of practical use, it is essential ... fast and easy to perform, with minimal sample preparation, and ...
Cached Biology Technology:A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 2A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 3A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 4A new LC/MS/MS Research Method for Rapid Quantitation of Five Immunosuppressant Drugs, including Mycophenolic Acid (MPA) 5Multiplexed Quantitative Peptide Assays for Protein Biomarkers of Cardiovascular Disease in Human Plasma 2Multiplexed Quantitative Peptide Assays for Protein Biomarkers of Cardiovascular Disease in Human Plasma 3Multiplexed Quantitative Peptide Assays for Protein Biomarkers of Cardiovascular Disease in Human Plasma 4Multiplexed Quantitative Peptide Assays for Protein Biomarkers of Cardiovascular Disease in Human Plasma 5A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors) 2A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors) 3A simple and rapid LC-MS/MS method for the simultaneous determination of nine antiretroviral drugs commonly used in Europe (protease Inhibitors and non-nucleoside reverse transcriptase inhibitors) 4
... for quick and reproducible immunoprecipitation (IP) by using ... more reproducible than regular IPs, which are problematic ... without disrupting the agarose bed. The binding of ... reversible, and elution of the immune complex can ...
... Kit (V2), 2 x 11K will ... of many thousands of yeast genes ... biological processes. Each microarray contains sequences ... from the S288C strain of Saccharomyces ...
... require screening through a huge volume ... data from normal biologic diversity. The ... available to help better manage the ... inherent to biomarker discovery. The CiphergenExpress ...
... Immunoprecipitation kit allows a rapid and ... active FLAG-tagged protein. The immunoprecipitation is ... is a highly specific monoclonal antibody ... use of affinity resin allows an ...
Biology Products: